Biotech Values

[DewDiligence]

JL et al re AMRN (in case you missed it):

http://www.nytimes.com/2011/05/03/health/research/03patterns.html

Men with the highest blood D.H.A. levels were 2.5 times more likely to develop high-grade, aggressive prostate cancer than those with the lowest D.H.A. levels, the researchers found. Another surprising finding was that men with the highest blood levels of trans fatty acids, which are harmful to the heart, had half the risk of aggressive prostate cancer compared with those who had the lowest levels. Both results confounded the scientists.

EPA can be converted to DHA in vivo, so this finding is potentially relevant to AMR101. The prostate-cancer finding could, of course, be a statistical fluke.